Bronchodilator reversibility increases in people with cystic fibrosis after initiation of Kaftrio - Vienna 2024

Pulmonary function testing: it's more than just spirometry!

Chair(s): Rachel Ong-Salvador, Ben Knox-Brown

Session type: Oral presentation

Bronchodilator reversibility increases in people with cystic fibrosis after initiation of Kaftrio

Saeeda Lone - Latif

EVENTS HOME

Previous presentation

Next presentation

Session content

Bronchodilator Response (BDR): Comparison of the ERS/ATS Technical Standard on Interpretative Strategies for Routine Lung Function with BTS/NICE Disease-Specific Guidelines

Ian Cliff

Replay

Poster

Abstract

Slides

Bronchodilator reversibility increases in people with cystic fibrosis after initiation of Kaftrio

Saeeda Lone - Latif

Replay

Poster

Abstract

Slides

Using % predicted change during bronchial challenge testing to remove bias

James Dean

Replay

Poster

Abstract

Slides

Comparison of lung function, functional capacity and performance status after lung transplantation with and without EVLP: a retrospective pilot study

Anouk Van T Veer

Replay

Poster

Abstract

Slides

The sensitivity of different lung function metrics to detect airways disease

Laurie Smith

Replay

Poster

Abstract

Slides

Detection of Idiopathic Pulmonary Fibrosis Disease Progression using Respiratory Oscillometry

Joyce Wu

Replay

Poster

Abstract

Slides

A physiologist-led home spirometry assessment (PLHSA) facilitates respiratory diagnosis and treatment pathways

Megan Robshaw

Replay

Poster

Abstract

Slides

Deposition and distribution of radiolabeled aerosol in individuals post COVID-19 infection

Armele Dornelas De Andrade

Replay

Poster

Abstract

Slides

The outcomes from introducing continuous laryngoscopy during exertion (CLE) to an exertional dyspnoea cardiopulmonary exercise testing (CPET) service.

Maximillian Thomas

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}